Changeflow GovPing Pharma & Drug Safety Methods for Rule-based Genome Design
Routine Notice Added Final

Methods for Rule-based Genome Design

Favicon for changeflow.com USPTO Patent Applications - Peptides (C07K)
Published
Detected
Email

Summary

USPTO published patent application US20260100251A1 for computer-implemented methods of rule-based genome design. The application covers systems receiving known genome data and allele lists, generating alternative gene sequences, and scoring each sequence using a weighted combination of multiple rules, constraints, or parameters. Inventors include George M. Church and Nili Ostrov.

What changed

USPTO published patent application US20260100251A1 for Methods for Rule-based Genome Design. The application discloses computer-implemented methods including receiving known genome data and allele lists, identifying and removing allele occurrences, generating alternative gene sequences, applying multiple rules or constraints to assign per-rule scores, and selecting sequences based on weighted scoring. The methods enable systematic design, testing, and validation of genome designs.

Affected parties include synthetic biology companies, genome engineering researchers, and computational biology platform developers who may wish to design genomes using similar rule-based approaches. Patent filing activity in this space may signal future licensing requirements or competitive considerations for genome design software developers.

What to do next

  1. Monitor for patent prosecution updates
  2. Review if genome design methods may implicate licensing obligations

Archived snapshot

Apr 10, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

Methods for Rule-based Genome Design

Application US20260100251A1 Kind: A1 Apr 09, 2026

Inventors

Gleb Kuznetsov, Marc J. Lajoie, Matthieu M. Landon, Michael G. Napolitano, Daniel Bryan Goodman, Christopher J. Gregg, George M. Church, Nili Ostrov

Abstract

Methods and systems for designing, testing, and validating genome designs based on rules or constraints or conditions or parameters or features and scoring are described herein. A computer-implemented method includes receiving data for a known genome and a list of alleles, identifying and removing occurrences of each allele in the known genome, determining a plurality of allele choices with which to replace occurrences in the known genome, generating a plurality of alternative gene sequences for a genome design based on the known genome, wherein each alternative gene sequence comprises a different allele choice, applying a plurality of rules or constraints or conditions or parameters or features to each alternative gene sequence by assigning a score for each rule or constraint or condition or parameter or feature in each alternative gene sequence, resulting in scores for the applied plurality of rules or constraints or conditions or parameters or features, scoring each alternative gene sequence based on a weighted combination of the scores for the plurality of rules or constraints or conditions or parameters or features, and selecting at least one alternative gene sequence as the genome design based on the scoring.

CPC Classifications

G16B 35/10 C07K 14/245 C12N 15/1089 C12P 21/00 G16B 20/50 A61K 38/00

Filing Date

2024-09-30

Application No.

18901470

View original document →

Get daily alerts for USPTO Patent Applications - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260100251A1

Who this affects

Applies to
Technology companies Research institutions Manufacturers
Industry sector
5112 Software & Technology
Activity scope
Patent application filing Genome engineering Bioinformatics
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Artificial Intelligence Data Privacy Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!